Work

Many facets of bortezomib resistance/susceptibility

Year: 2008

Type: article

Abstract: In this issue of Blood , Oerlemans and colleagues present a fascinating report, detailing a mechanism by which cells acquire resistance to therapy with the proteasome inhibitor, bortezomib. Proteasome inhibition represents one of the most successful anticancer strategies of this decade, improving

Source: Blood

DOI: 10.1182/blood-2008-07-167767

Authors: Shaji Kumar, S. Vincent Rajkumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2088081193